PCVX - Vaxcyte, Inc.
59.29
1.040 1.754%
Share volume: 1,444,104
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$58.25
1.04
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-05-2024 | 02-25-2025 | 05-07-2025 | 11-04-2025 | 02-24-2026 | |
| Cash flow financing | 818.196 M | 110.368 M | 1.515 B | 4.907 M | 759.000 K | -3.671 M | 2.408 M | |
| Other financing cash flows | 1.718 M | 2.179 M | 2.401 M | -20.590 M | 759.000 K | -3.977 M | -1.007 M | |
| Cash flow | 207.999 M | -91.432 M | 537.310 M | -663.662 M | -42.198 M | -25.806 M | -107.299 M | |
| Net income | -95.020 M | -128.703 M | -103.124 M | -137.080 M | -140.718 M | -212.830 M | -246.507 M | |
| Depreciation | 999.000 K | 1.352 M | 1.788 M | 2.864 M | 2.956 M | 3.064 M | 7.497 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -451.073 M | -80.406 M | -917.019 M | -557.168 M | 123.317 M | 121.170 M | 115.125 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -6.394 M | -31.199 M | -33.133 M | -26.006 M | -21.327 M | -8.222 M | -5.767 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 5.678 M | 7.781 M | 4.947 M | 4.021 M | 5.424 M | 3.824 M | 2.654 M | |
| Cash Change | 214.061 M | -92.842 M | 531.734 M | -662.312 M | -41.026 M | -25.515 M | -107.123 M |